Trials / No Longer Available
No Longer AvailableNCT02570412
Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy
Compassionate Use of Aldoxorubicin in Sarcoma Patients Who Have Failed Prior Chemotherapy
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- CytRx · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Compassionate use of aldoxorubicin in sarcoma patients who have failed prior chemotherapy.
Detailed description
This is a compassionate use protocol allowing sarcoma patients that have relapsed after prior therapies and are not eligible for other protocols involving the evaluation of aldoxorubicin to receive aldoxorubicin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aldoxorubicin | aldoxorubicin administered at 350 mg/m2 |
Timeline
- First posted
- 2015-10-07
- Last updated
- 2015-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02570412. Inclusion in this directory is not an endorsement.